The global blood clot retrieval devices market was valued at around US$ 1.4 Billion at the end of 2021. The market is projected to register a 15.0% CAGR and top a valuation of US$ 5.7 Billion by 2032.
“The accelerating trend of transplantation and the increasing need for stem cell banking are further factors contributing to the expansion of the blood clot retrieval devices market.”
The danger of paralysis or brain damage is reduced by the use of blood clot retrieval devices. This surgical procedure aids in removing the patient's blood clots from the brain. Patients with blood clots in the brain undergo an invasive surgery that involves arteries going to the brain. Blood clot retrieval devices are used to treat two main types of strokes, ischemic and hemorrhagic, both of which are brought on by impaired blood flow to the brain.
Thrombectomy devices, commonly referred to as blood clot retrieval devices are useful in eliminating blood clots by broadening the arteries. When blood clots form in the brain, retrieval devices for blood clots can be very effective in the removal process.
| Attributes | Details |
|---|---|
| Blood Clot Retrieval Devices Market Value in 2021 | US$ 1.4 Billion |
| Blood Clot Retrieval Devices Market Value in 2032 | US$ 5.7 Billion |
| Blood Clot Retrieval Devices Market CAGR (2022 to 2032) | 15.0% |
Blood clot retrieval devices are in demand as people are becoming more aware of the advantageous reimbursement policies that exist in the majority of countries and the accessibility of minimally invasive surgery options. The market for blood clot retrieval devices is expanding as a result of the availability of advanced healthcare infrastructure. The market is expanding as a result of rising disposable income among people. Spending on medical facilities has increased as a result of rising disposable income. The market is anticipated to expand significantly throughout the forecast period as surgeons are increasingly favoring image-guided procedures.
The prevalence of ischemic strokes, hemorrhagic strokes, and transient ischemic strokes is predicted to rise as a result of people's unhealthy lifestyles. The market for blood clot retrieval devices is expanding as a result of the rising incidence of stroke in elderly patients due to the aging population. The market's expansion will also be aided by regulatory approval for these devices that comply with all rules and regulations as a result of an increase in technological improvements and the introduction of new technologies in the market.
Globally, the market for blood clot retrieval devices is dominated by North America. The increase in the number of patients undergoing surgeries and the availability of technologically advanced medical devices.
The European blood clot retrieval devices market is also second in line in the global market due to the rising demand for blood clot retrieval devices owing to the increasing number of deaths due to strokes.
The East Asian region is predicted to show lucrative growth due to the growing partnerships between international players and regional market players the blood clot retrieval devices market.
AngioDynamics Inc., Terumo Co., Johnson and Johnson, ECKOS Co., Bayer HealthCare LLC, Boston Scientific Co., Argon Medical Devices, Medtronic Plc, Teleflex Incorporated, Penumbra.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 15.0% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Stroke Type, Device, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | AngioDynamics; Terumo Co.; Johnson and Johnson; ECKOS Co.; Bayer HealthCare LLC; Boston Scientific Co.; Argon Medical Devices; Medtronic Plc; Teleflex Incorporated; Penumbra |
| Customization | Available Upon Request |
The global blood clot retrieval devices market is anticipated to register a CAGR of 15.0% during the forecast period.
The global blood clot retrieval devices market is projected to be about US$ 5.7 Bn by the end of year 2032.
Explore Similar Insights
Blood Clot Retrieval Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
